NCT01755481
Completed
Not Applicable
Feeding Infant Formula With Added Probiotics and Whey Protein Concentrate
Arla Foods1 site in 1 country800 target enrollmentStarted: December 2012Last updated:
ConditionsFocus on Healthy Infants
Overview
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Arla Foods
- Enrollment
- 800
- Locations
- 1
- Primary Endpoint
- Infections episodes (gastrointestinal and upper and lower respiratory infections)
Overview
Brief Summary
To evaluate the effects of feeding an infant formula containing L. paracasei ssp. paracasei strain F19 or Whey Protein Concentrate.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Prevention
- Masking
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Eligibility Criteria
- Ages
- — to 2 Weeks (Child)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Infections episodes (gastrointestinal and upper and lower respiratory infections)
Time Frame: 4 yrs
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Terminated
Not Applicable
The Effect of Feeding Infant Formula Containing Prebiotics and/or ProbioticsMetabolomicsNCT02948114Mead Johnson Nutrition2
Completed
Not Applicable
Supplementation of Infant Formula With SynbioticsInfant FormulaNCT01625273Arla Foods182
Completed
Not Applicable
The Effects of an Infant Formula Containing Probiotic CECT7210 on Gastrointestinal HealthGastrointestinal DiseasesNCT02096302Laboratorios Ordesa194
Withdrawn
Phase 2
Colonisation Resistance StudyHealthy InfantsNCT01507935Danone Asia Pacific Holdings Pte, Ltd.
Completed
Not Applicable
Color Synbiotics StudyBeneficial Bacteria in GutNCT01813175Danone Asia Pacific Holdings Pte, Ltd.290